Product NewsNovel Diagnostic Test Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer
Product NewsMammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC
